Shenzhen Chipscreen Biosciences Co., Ltd.
SSE:688321.SS
22.9 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 657.949 | 515.786 | 529.939 | 430.45 | 269.47 | 173.8 | 147.689 | 110.503 | 85.364 |
| Cost of Revenue
| 87.469 | 56.969 | 29.992 | 21.578 | 13.475 | 7.29 | 5.511 | 5.259 | 2.167 |
| Gross Profit
| 570.481 | 458.817 | 499.948 | 408.872 | 255.995 | 166.511 | 142.178 | 105.245 | 83.197 |
| Gross Profit Ratio
| 0.867 | 0.89 | 0.943 | 0.95 | 0.95 | 0.958 | 0.963 | 0.952 | 0.975 |
| Reseach & Development Expenses
| 213.518 | 270.445 | 163.672 | 130.026 | 92.291 | 51.443 | 43.161 | 37.586 | 32.38 |
| General & Administrative Expenses
| 20.773 | 21.235 | 27.676 | 33.09 | 19.77 | 12.641 | 10.223 | 20.77 | 23.707 |
| Selling & Marketing Expenses
| 177.318 | 136.307 | 245.565 | 212.762 | 119.128 | 73.548 | 51.129 | 31.988 | 24.402 |
| SG&A
| 198.091 | 157.542 | 273.241 | 245.852 | 138.898 | 86.189 | 61.352 | 52.758 | 48.109 |
| Other Expenses
| 337.375 | -58.318 | 45.74 | 17.545 | 5.164 | 17.515 | -0.473 | 1.399 | 0.846 |
| Operating Expenses
| 748.983 | 369.67 | 482.653 | 393.423 | 236.353 | 155.147 | 113.641 | 78.008 | 81.69 |
| Operating Income
| -178.503 | 97.072 | 35.234 | 22.26 | 36.982 | 21.669 | 32.64 | 24.536 | 2.028 |
| Operating Income Ratio
| -0.271 | 0.188 | 0.066 | 0.052 | 0.137 | 0.125 | 0.221 | 0.222 | 0.024 |
| Total Other Income Expenses Net
| 81.791 | -0.053 | -20.077 | -3.66 | -0.813 | -0.934 | -0.473 | -0.878 | 3.216 |
| Income Before Tax
| -96.712 | 97.019 | 15.157 | 18.6 | 36.169 | 20.735 | 32.167 | 23.657 | 5.244 |
| Income Before Tax Ratio
| -0.147 | 0.188 | 0.029 | 0.043 | 0.134 | 0.119 | 0.218 | 0.214 | 0.061 |
| Income Tax Expense
| 17.859 | 47.831 | 2.341 | -3.358 | 5.123 | 1.313 | 1.002 | -0.416 | 5.817 |
| Net Income
| -114.571 | 88.839 | 12.816 | 21.958 | 31.046 | 19.422 | 31.165 | 24.074 | 5.244 |
| Net Income Ratio
| -0.174 | 0.172 | 0.024 | 0.051 | 0.115 | 0.112 | 0.211 | 0.218 | 0.061 |
| EPS
| -0.28 | 0.22 | 0.032 | 0.054 | 0.076 | 0.047 | 0.087 | 0.069 | 0.016 |
| EPS Diluted
| -0.28 | 0.22 | 0.032 | 0.054 | 0.076 | 0.047 | 0.087 | 0.069 | 0.016 |
| EBITDA
| -3.43 | 187.44 | 78.046 | 44.733 | 49.096 | 27.362 | 37.664 | 30.079 | 12.36 |
| EBITDA Ratio
| -0.005 | 0.363 | 0.147 | 0.104 | 0.182 | 0.157 | 0.255 | 0.272 | 0.145 |